5 companies list denosumab as a human prescription drug in the openFDA NDC Directory, led by Fresenius Kabi USA, LLC, Amgen, Inc, Sandoz Industrial Products S.A, Organon LLC, Cordavis Limited. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.

Who supplies denosumab active ingredient?

2 companies list denosumab as a bulk ingredient, including Novartis Pharmaceuticals Corporation, Samsung Biologics Co., Ltd..

Drug

Who makes denosumab?

5 companies list denosumab as a human prescription drug, including under the names BILDYOS, BOMYNTRA, Bilprevda, CONEXXENCE, JUBBONTI, OSPOMYV, Prolia, WYOST. Forms: injection; injection, solution. Routes: subcutaneous.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing denosumab

Company	Forms	Application	NDCs	Registered sites
Fresenius Kabi USA, LLCUnited States	injection	BLABLA761398	3	6
Amgen, IncUnited States	injection	BLABLA125320	2	9
Sandoz Industrial Products S.AAustria	injection	BLABLA761362	2	5
Organon LLCNetherlands	injection, solution	BLABLA761444	2	4
Cordavis Limited	injection, solution	BLABLA761392	1	0

Bulk ingredient listings

Novartis Pharmaceuticals CorporationSwitzerland · 1 NDC
Samsung Biologics Co., Ltd.United States · 1 NDC

Enquiry

Common questions

Who makes denosumab?: 5 companies list denosumab as a human prescription drug in the openFDA NDC Directory, led by Fresenius Kabi USA, LLC, Amgen, Inc, Sandoz Industrial Products S.A, Organon LLC, Cordavis Limited. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Who supplies denosumab active ingredient?: 2 companies list denosumab as a bulk ingredient, including Novartis Pharmaceuticals Corporation, Samsung Biologics Co., Ltd..